Latest / Breastcancer.org Podcast

Immunotherapy to Treat Metastatic HER2-Positive Breast Cancer: ESMO 2019 Coverage
Dr. Leisha Emens is professor of medicine in hematology/oncology at the University of Pittsburgh Hillman Cancer Center. She is also co-leader of the Hillman Cancer Immunology and Immunotherapy Program and director of translational immunotherapy for the Women’s Cancer Research Center. She is internationally recognized for her work in breast cancer immunotherapy.
At the European Society for Medical Oncology 2019 Congress, she presented overall survival results from the KATE2 study, which compared using the combination of Tecentriq, also called atezolizumab, and Kadcyla, also called T-DM1, to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.